Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael F Good

Showing results (91-100 of 215) with videos related to

Pageof 22
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2015
A synthetic M protein peptide synergizes with a CXC chemokine protease to induce vaccine-mediated protection against virulent streptococcal pyoderma and bacteremiaManisha Pandey, Emma Langshaw, Jon Hartas, et al.
Advances in Experimental Medicine and Biology|April 30, 2009
Vaccine delivery: synthesis and investigation of a highly pure, multi-epitopic lipopeptide vaccine candidateIstvan Toth, Peter M Moyle, Pavla Simerska, et al.
Trends in Parasitology|August 6, 2022
A vaccine for human babesiosis: prospects and feasibilityHanan Al-Nazal, Leanne M Low, Sanjai Kumar, et al.
Bioconjugate Chemistry|April 10, 2014
Site-specific incorporation of three toll-like receptor 2 targeting adjuvants into semisynthetic, molecularly defined nanoparticles: application to group a streptococcal vaccinesPeter M Moyle, Wei Dai, Yingkai Zhang, et al.
The Indian Journal of Medical Research|July 3, 2004
Group A streptococcal vaccine delivery by immunization with a self-adjuvanting M protein-based lipid core peptide constructColleen Olive, Michael Batzloff, Aniko Horváth, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|February 23, 2013
An efficient, chemically-defined semisynthetic lipid-adjuvanted nanoparticulate vaccine development systemPeter M Moyle, Jon Hartas, Anna Henningham, et al.
Infection and Immunity|April 22, 2003
Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogensColleen Olive, Michael Batzloff, Aniko Horváth, et al.
Acta Biomaterialia|August 22, 2016
A semi-synthetic whole parasite vaccine designed to protect against blood stage malariaAshwini Kumar Giddam, Jennifer M Reiman, Mehfuz Zaman, et al.
Immunology|September 19, 2008
Soluble CD38 significantly prolongs the lifespan of memory B-cell responsesXue Q Liu, Derek N J Hart, Gordon G MacPherson, et al.
The Journal of Clinical Investigation|July 15, 2010
Low doses of killed parasite in CpG elicit vigorous CD4+ T cell responses against blood-stage malaria in miceAlberto Pinzon-Charry, Virginia McPhun, Vivian Kienzle, et al.
Pageof 22

Showing results (91-100 of 215) with videos related to

Sort By:
Pageof 22
Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2015
A synthetic M protein peptide synergizes with a CXC chemokine protease to induce vaccine-mediated protection against virulent streptococcal pyoderma and bacteremiaManisha Pandey, Emma Langshaw, Jon Hartas, et al.
Advances in Experimental Medicine and Biology|April 30, 2009
Vaccine delivery: synthesis and investigation of a highly pure, multi-epitopic lipopeptide vaccine candidateIstvan Toth, Peter M Moyle, Pavla Simerska, et al.
Trends in Parasitology|August 6, 2022
A vaccine for human babesiosis: prospects and feasibilityHanan Al-Nazal, Leanne M Low, Sanjai Kumar, et al.
Bioconjugate Chemistry|April 10, 2014
Site-specific incorporation of three toll-like receptor 2 targeting adjuvants into semisynthetic, molecularly defined nanoparticles: application to group a streptococcal vaccinesPeter M Moyle, Wei Dai, Yingkai Zhang, et al.
The Indian Journal of Medical Research|July 3, 2004
Group A streptococcal vaccine delivery by immunization with a self-adjuvanting M protein-based lipid core peptide constructColleen Olive, Michael Batzloff, Aniko Horváth, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|February 23, 2013
An efficient, chemically-defined semisynthetic lipid-adjuvanted nanoparticulate vaccine development systemPeter M Moyle, Jon Hartas, Anna Henningham, et al.
Infection and Immunity|April 22, 2003
Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogensColleen Olive, Michael Batzloff, Aniko Horváth, et al.
Acta Biomaterialia|August 22, 2016
A semi-synthetic whole parasite vaccine designed to protect against blood stage malariaAshwini Kumar Giddam, Jennifer M Reiman, Mehfuz Zaman, et al.
Immunology|September 19, 2008
Soluble CD38 significantly prolongs the lifespan of memory B-cell responsesXue Q Liu, Derek N J Hart, Gordon G MacPherson, et al.
The Journal of Clinical Investigation|July 15, 2010
Low doses of killed parasite in CpG elicit vigorous CD4+ T cell responses against blood-stage malaria in miceAlberto Pinzon-Charry, Virginia McPhun, Vivian Kienzle, et al.
Pageof 22